Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Iovance Biotherapeutics Inc
(NQ:
IOVA
)
8.940
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
8.940
Bid (Size)
8.710 (1)
Ask (Size)
9.450 (5)
Prev. Close
8.940
Today's Range
8.940 - 8.940
52wk Range
3.210 - 18.33
Shares Outstanding
279,832,722
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
7 ‘Death Cross’ Stocks That Could Be Contrarian Buys
July 17, 2024
Although death cross stocks sound incredibly ominous, they could be the ideal time to consider a contrarian position.
Via
InvestorPlace
Is Iovance Biotherapeutics a Millionaire Maker?
July 14, 2024
This biotech's future is bright, but how good could it get for investors?
Via
The Motley Fool
Performance
YTD
+10.37%
+10.37%
1 Month
+10.64%
+10.64%
3 Month
-24.24%
-24.24%
6 Month
+11.19%
+11.19%
1 Year
+9.69%
+9.69%
More News
Read More
3 Under-$10 Biotech Stocks That Could Make You Rich
July 11, 2024
Via
InvestorPlace
Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
July 11, 2024
Via
Benzinga
What's Going On With Iovance Biotherapeutics Today?
May 24, 2024
Via
Benzinga
Iovance Biotherapeutics's Options: A Look at What the Big Money is Thinking
May 10, 2024
Via
Benzinga
How Is The Market Feeling About Iovance Biotherapeutics?
May 09, 2024
Via
Benzinga
Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
June 28, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Is It Too Late to Buy Iovance Biotherapeutics Stock?
June 28, 2024
Via
The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
June 21, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
3 Top Penny Stocks to Skyrocket Your Wealth in 2024
June 21, 2024
Via
InvestorPlace
The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why
June 10, 2024
Via
The Motley Fool
Oncotelic Therapeutics (OTC: OTLC) Inks Deal With Mosaic ImmunoEngineering To Sell Clinical-Stage Necroptosis Cancer Therapy Assets
May 29, 2024
Via
News Direct
Exposures
Product Safety
Iovance Biotherapeutics to Present at Upcoming Conferences and Events
May 24, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
May 24, 2024
Via
Benzinga
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
May 23, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
May 22, 2024
Via
The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
May 17, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
4 Small-Cap Value Stocks That Could Go Parabolic
May 16, 2024
Via
The Motley Fool
The 3 Most Undervalued Biotech Stocks to Buy in May 2024
May 11, 2024
Via
InvestorPlace
Why Iovance Stock Is Down 18% Today
May 10, 2024
Via
The Motley Fool
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 10, 2024
Via
Benzinga
IOVA Stock Earnings: Iovance Biotherapeutics Meets EPS, Misses Revenue for Q1 2024
May 09, 2024
Via
InvestorPlace
Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
May 09, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.